REFERENCES
- Canadian Pharmacists Association. CPS: Compendium of Pharmaceuticals and Specialties. C. Repchinsky, Editor in Chief. Canadian Pharmacists Association. Ottawa. 2002; 634–635, 706, 1143–1144, 1750–1751, and 1757.
- Bowes, A. de P. In: Lippincott J.B., Editor, Bowes and Church's Food Values of Portions Commonly Used. Philadelphia, PA: Lippincott, Williams and Wilkins, 1994; 381–382.
- Gelal A., Guven H., Balkan D., Artok L., and Benowitz N.L. Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers. Eur. J. Clin. Pharmacol. 2003; 59(5–6): 417–422.
- Kaplan G.B., Greenblatt D.J., Ehrenberg B.L., Goddard J.E., Cotreau M.M., Harmatz J.S., and Shader R.I. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J. Clin. Pharmacol. 1997; 37(8): 693–703.
- D.J. Miners and Miners J.O. Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events. Br. J. Clin. Pharmacol. 1991; 31(4): 405–408.
- Bonati M., Latini R., Galletti F., Young J.F., Tognoni G., and Garattini S. Caffeine disposition after oral doses. Clin. Pharmacol. Ther. 1982; 32(1): 98–106.
- Pentel P. Toxicity of over-the-counter stimulants. J.A.M.A. 1984; 252(14): 1898–1903.
- Botella P. and Parra A. Coffee increases state anxiety in males but not in females. Hum. Psychopharmacol. Clin. Exp. 2003; 18(2): 141–143.
- Avisar R., Avisar E., and Weinberger D. Effect of coffee consumption on intraocular pressure. Ann. Pharmacother. 2002; 36(6): 992–995.
- Freestone S. and Ramsay L.E. Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients. Am. J. Med. 1982; 73(3): 348–353.
- Dorfman L.J. and Jarvik M.E. Comparative stimulant and diuretic actions of caffeine and theobromine in man. Clin. Pharmacol. Ther. 1970; 11(6): 869–872.
- Dimaio V.J.M. and Garriott J.C. Lethal caffeine poisoning in a child. Forensic Sci. 1974; 3(3): 275–278.
- Fligner C.L. and Opheim K.E. Caffeine and its dimethylxanthine metabolites in two cases of caffeine overdose: a cause of falsely elevated theophylline concentrations in serum. J. Anal. Toxicol. 1988; 12(6): 339–343.
- Garriott J.C., Simmons L.M., Poklis A., and Mackell M.A. Five cases of fatal overdose from caffeine-containing “look-alike” drugs. J. Anal. Toxicol. 1985; 9(3): 141–143.
- Leson C.L., McGuigan M.A., and Bryson S.M. Caffeine overdose in an adolescent male. J. Toxicol. Clin. Toxicol. 1988; 26(5–6): 407–415.
- McGee M.B. Caffeine poisoning in a 19-year-old female. J. Forensic Sci. 1980: 25(1): 29–32.
- Shum S., Seale C., Hathaway D., Chucovich V., and Beard D. Acute caffeine ingestion fatalities: management issues. Vet. Hum. Toxicol. 1997; 39(4): 228–230.
- Turner J.E. and Cravey R.H. A fatal ingestion of caffeine. Clin. Toxicol. 1977; 10(3): 341–344.
- Anderson B.J., Gunn T.R., Holford N.H.G., and Johnson R. Caffeine overdose in a premature infant: clinical course and pharmacokinetics. Anaesth. intens. Care. 1999; 27(3): 307–311.
- Alstott R.L., Miller A.J., and Forney R.B. Report of a human fatality due to caffeine. J. Forensic Sci. 1973; 18(2): 135–137.
- Hanzlick R., Gowitt G.T., and Wall W. Deaths due to caffeine in “look-alike drugs”. J. Anal. Toxicol. 1986; 10(3): 126.
- Ryall J.E. Caffeine and ephedrine fatality. Bulletin—The International Academy of Forensic Toxicologists. 1984; 17: 13.
- Winek C.L., Wahba W., Williams K., Blenko J., and Janssen J. Caffeine fatality: a case report. Forensic Sci. Int. 1985; 29(3–4): 207–211.
- Holmgren P., Nordén-Pettersson L., and Ahlner J. Caffeine fatalities—four case reports. Forensic Sci. Int. 2004; 139(1): 71–73.
- The Pharmaceutical Society of Great Britain, Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-mortem material. 2nd Edition, Jackson J.V., Moss M.S., and Widdop B., Editors, London: The Pharmaceutical Press, 1986; 420–422.
- Machata G. Determination of alcohol in blood by gas chromatography head space analysis. Clin. Chem. Newsletter. 1972; 4: 29–32.
- Koves E.M. and Wells, J. An evaluation of fused silica capillary columns for the screening of basic drugs in postmortem blood: qualitative and quantitative analysis. J. Forensic Sci. 1985; 30(3): 692–707.
- Katsumata Y., Aoki M., Sato K., Suzuki O., Oya M., and Yada S. A simple spectrophotometry for determination of carboxyhemoglobin in blood. J. Forensic Sci. 1982; 27(4): 928–934.
- Jones A.W., Sagarduy A., Ericsson E., and Arnqvist H.J. Concentrations of acetone in venous blood samples from drunk drivers, type-I diabetic outpatients and healthy blood donors. J. Anal. Toxicol. 1993; 17(3): 182–185.
- Wigmore J.G. and Chow B.L.C. Case report: detection of neo-formation of ethanol in a postmortem blood sample using n-propanol and a urine sample. Can. Soc. Forensic Sci. J. 2000; 33(3): 145–149.
- Costell J.F., May C.S., Paterson J.W., and Pickup M.E. Pharmacokinetics of ephedrine in asthmatics receiving acute and chronic treatment. Br. J. Clin. Pharmacol. 1975; 2: 180–181.
- White L.M., Gardner S.F., Gurley B.J., Marx M.A., Wang P.L., and Estes M. Pharmacokinetics and cardiovascular effects of Ma-Huang (Ephedra sinica) in normotensive adults. J. Clin. Pharmacol. 1997; 37: 116–122.
- Stewart R.D., Baretta E.D., Platte L.R., Stewart E.B., Kalbfleisch J.H., Van Yserloo B., and Rimm A.A. Carboxyhemoglobin levels in American blood donors. J.A.M.A. 1974; 229(9): 1187–1195.
- Kelly M.W., Perry P.J., Holstad S.G., and Garvey M.J. Serum fluoxetine and norfluoxetine concentrations and antidepressant response. Ther. Drug. Monit. 1989; 11(2): 165–170.
- Borys D.J., Setzer S.C., Ling L.J., Reisdorf J.J., Day L.C., and Krenzelok E.P. Acute fluoxetine overdose: a report of 234 cases. Am. J. Emerg. Med. 1992; 10(2): 115–120.
- Borys D.J., Setzer S.C., Ling L.J., Reisdorf J.J., Day L.C., and Krenzelok E.P. The effects of fluoxetine in the overdose patient. J. Toxicol. Clin. Toxicol. 1990; 28(3): 331–340.
- Kincaid R.L., McMullin M.M., Crookham S.B., and Rieders F. Report of a fluoxetine fatality. J. Anal. Toxicol. 1990; 14(5): 327–329
- Carillo J.A. and Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin. Pharmacokinet. 2000; 39(2): 127–153.